Signaling pathway critical in the development of type 2 and cancer may offer diabetes treatment possibility…
Read More »Yearly Archives: 2014
Kidney Function Found to be Affected by Perceived Racial Discrimination
According to a new study, perceived racial discrimination may contribute to disparities in rates of decline… Psychosocial factors such as perceived racial discrimination have been associated with chronic diseases, but little is known about the relationship between perceived racial discrimination and kidney function decline. Researchers led by Angedith Poggi-Burke, MPH …
Read More »Editor’s Note, Insulin Special Edition, December 2014
Last month I shared an event that occurred in the pharmacy concerning a 22-year-old man with type 1 diabetes who came to see me after his hospitalization for severe DKA. This past weekend he came into the pharmacy to refill his insulin and strips and I took a minute to …
Read More »Updated: Cholesterol-Lowering Treatment Options
We’ve recently updated this important list which includes dosing range, average lowering of LDL, side effects and generic availability. Download the PDF (4 pages) and post in your office today: Cholesterol-Lowering Treatment Options.
Read More »Animas Vibe Plus CGMS
Animas Vibe Plus CGMS The FDA has approved the Animas Vibe insulin pump and continuous glucose monitoring (CGM) system for management of patients with diabetes who require insulin. The integrated system, which features Dexcom G4 Platinum sensing technology, allows patients to view glucose data and administer insulin from the pump. …
Read More »Letter from the Editor, #758
It has been about five years since Dr. Steven Nissen started his public attack on the TZDs. His outspoken observations drove many prescribers away from using pioglitazone or rosiglitazone, and the FDA even agreed with his opinions, which drove the rest of us to stop using the medication all together. …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 8
In this week’s Homerun Slides, Dr. Stanley Schwartz reviews pioglitazone as a therapy for both diabetes and cardiovascular issues. Topics include: Pioglitazone in Dysmetabolic Syndrome, Prediabetes, Type 2 Diabetes; Effect of Pioglitazone on Cardiac Mass and Function: and Glitazones (including rosiglitazone) and Cardiac Function…. To download these slides in PowerPoint (.ppt) format, …
Read More »Editor’s Note, DCMS #217
It appears that the weather this winter may turn out to be worse than last year’s. Even here in sunny St. Petersburg, Fla., I had to pull out the winter gear for cycling. During these cold times patients often complain about their feet hurting more than usual. This could be …
Read More »Handbook of Diabetes, 4th Ed., Excerpt #20: Foot Problems in Diabetes
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP The high-risk diabetic foot The lifetime risk of a person with diabetes developing foot ulceration is around 25%. Recent studies suggest that the population-based incidence of diabetic foot ulcers is 1-4% with a prevalence of 4-10%. The risk of amputation is 10–30-fold …
Read More »Young Capillaries Can Rejuvenate Older Beta Cells
Targeting inflammation and fibrosis in the small blood vessels of the pancreatic islets may offer a new way of treatment….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.